Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cayman Chemical T-1095, Purity: ≥98%, CAS: 209746-59-8, 10 mg
SDP

Catalog No. 502917372
Encompass_Preferred

An SGLT1 and SGLT2 inhibitor (IC50s = 22.8 and 2.3 µM, respectively); dietary administration reduces blood glucose and HbA1c levels in a rat model of streptozotocin-induced diabetes at 0.01% w/w; suppresses the development of hyperglycemia and hypertriglyceridemia and reduces HbA1c levels in the KKAγ mouse model of type 2 diabetes; exacerbates post-infarction cardiac dysfunction in a rat model of left anterior descending coronary artery ligation-induced myocardial infarction

Catalog No. 50-291-7372 Supplier Cayman Chemical Supplier No. 3728410 MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

An SGLT1 and SGLT2 inhibitor (IC50s = 22.8 and 2.3 µM, respectively); dietary administration reduces blood glucose and HbA1c levels in a rat model of streptozotocin-induced diabetes at 0.01% w/w; suppresses the development of hyperglycemia and hypertriglyceridemia and reduces HbA1c levels in the KKAγ mouse model of type 2 diabetes; exacerbates post-infarction cardiac dysfunction in a rat model of left anterior descending coronary artery ligation-induced myocardial infarction

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.